SHIRE 465 50 mg Pill - purple white capsule/oblong, 22mm
Generic Name: amphetamine/dextroamphetamine
Pill with imprint SHIRE 465 50 mg is Purple / White, Capsule/Oblong and has been identified as Mydayis 50 mg. It is supplied by Shire US, Inc.
Mydayis is used in the treatment of ADHD and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Mydayis 50 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for SHIRE 465 50 mg
Mydayis
- Generic Name
- amphetamine/dextroamphetamine
- Imprint
- SHIRE 465 50 mg
- Strength
- 50 mg
- Color
- Purple / White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Shire US, Inc.
- National Drug Code (NDC)
- 54092-0477
- Inactive Ingredients
-
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
sucrose,
magnesium silicate,
triethyl citrate,
D&C Red No. 28,
D&C Red No. 33,
titanium dioxide,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
More about Mydayis (amphetamine / dextroamphetamine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (142)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: CNS stimulants
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
